What is Global Drug Eluting Balloons (DEB) Market?
The Global Drug Eluting Balloons (DEB) Market is a dynamic and rapidly evolving sector that has gained significant attention in recent years. Drug Eluting Balloons, also known as DEBs, are a type of medical device used in the treatment of various cardiovascular diseases. They are coated with a drug that helps prevent the recurrence of narrowing arteries after angioplasty, a procedure to open blocked or narrowed coronary arteries. The global DEB market was valued at a substantial US$ 584 million in 2023 and is projected to reach an impressive US$ 1396.1 million by 2030. This growth trajectory represents a Compound Annual Growth Rate (CAGR) of 13.1% during the forecast period from 2024 to 2030. The market is dominated by the top 5 manufacturers who collectively hold a commanding share of over 84%. In terms of product differentiation, Peripheral DEBs represent the largest segment, accounting for a significant share of over 57%.
Peripheral DEBs, Coronary DEBs in the Global Drug Eluting Balloons (DEB) Market:
The Global Drug Eluting Balloons (DEB) Market is segmented into two main categories: Peripheral DEBs and Coronary DEBs. Peripheral DEBs are primarily used in the treatment of peripheral artery disease (PAD), a common circulatory problem in which narrowed arteries reduce blood flow to the limbs. On the other hand, Coronary DEBs are used in the treatment of coronary artery disease (CAD), a condition that involves the reduction of blood flow to the heart muscle due to the build-up of plaque in the arteries. Both types of DEBs play a crucial role in the treatment of these diseases, offering a less invasive and more effective solution compared to traditional methods. The market for these devices is driven by the increasing prevalence of cardiovascular diseases, advancements in technology, and the growing demand for minimally invasive procedures.
Catheterization Laboratory, Hospital, Others in the Global Drug Eluting Balloons (DEB) Market:
The usage of Drug Eluting Balloons (DEB) is widespread and can be found in various areas such as Catheterization Laboratories, Hospitals, and other medical facilities. In Catheterization Laboratories, DEBs are used in angioplasty procedures to open blocked or narrowed coronary arteries. They are also used in hospitals for the treatment of patients suffering from various cardiovascular diseases. The use of DEBs in these settings has proven to be highly effective, reducing the risk of restenosis and offering a better quality of life for patients. Other areas where DEBs are used include outpatient clinics and research institutions. The versatility and effectiveness of DEBs have made them a popular choice in the medical field, contributing to the growth of the Global Drug Eluting Balloons (DEB) Market.
Global Drug Eluting Balloons (DEB) Market Outlook:
The future outlook for the Global Drug Eluting Balloons (DEB) Market is promising. In 2023, the market was valued at US$ 584 million and is expected to reach a staggering US$ 1396.1 million by 2030. This represents a Compound Annual Growth Rate (CAGR) of 13.1% during the forecast period from 2024 to 2030. The market is largely dominated by the top 5 manufacturers who collectively hold a share of over 84%. In terms of product differentiation, Peripheral DEBs represent the largest segment, accounting for a significant share of over 57%. This data indicates a strong growth trajectory for the DEB market, driven by technological advancements, increasing prevalence of cardiovascular diseases, and the growing demand for minimally invasive procedures.
| Report Metric | Details |
| Report Name | Drug Eluting Balloons (DEB) Market |
| Accounted market size in 2023 | US$ 584 million |
| Forecasted market size in 2030 | US$ 1396.1 million |
| CAGR | 13.1% |
| Base Year | 2023 |
| Forecasted years | 2024 - 2030 |
| Segment by Type |
|
| Segment by Application |
|
| Consumption by Region |
|
| By Company | B. Braun, Medtronic, Boston Scientific, BD, Yinyi, Philips, Eurocor, Aachen Resonance, Biotronic |
| Forecast units | USD million in value |
| Report coverage | Revenue and volume forecast, company share, competitive landscape, growth factors and trends |
